广发纳斯达克生物科技人民币(001092)

动态评分: 5.30分

投资组合

报告日期 名称 比例
2023-12-31 Erasca Inc 0.03%
2023-12-31 Nautilus Biotechnology Inc 0.03%
2023-12-31 Precigen Inc 0.03%
2023-12-31 Y-mAbs Therapeutics Inc 0.03%
2023-12-31 Coherus BioSciences Inc 0.03%
2023-12-31 ATAI Life Sciences NV 0.02%
2023-12-31 Vanda Pharmaceuticals Inc 0.02%
2023-12-31 Atea Pharmaceuticals Inc 0.02%
2023-12-31 美国辉宝 0.02%
2023-12-31 Ovid Therapeutics Inc 0.02%
2023-12-31 Cartesian Therapeutics Inc 0.01%
2023-12-31 Karyopharm Therapeutics Inc 0.01%
2023-12-31 蓝鸟生物 0.01%
2023-12-31 Aclaris Therapeutics Inc 0.01%
2023-12-31 NGM Biopharmaceuticals Inc 0.01%
2023-12-31 Mural Oncology plc 0.01%
2023-12-31 Ventyx Biosciences Inc 0.01%
2023-12-31 Atara Biotherapeutics Inc 0%
2023-12-31 Cara Therapeutics Inc 0%
2023-12-31 NanoString Technologies Inc 0%

投资模拟

公告&资料